LONDON (Alliance News) - Hikma Pharmaceuticals PLC said Darhold Ltd, a company in which some of its directors are interested, purchased a total of 150,000 shares at a price of 2,138 pence per share on Thursday.
Chairman and Chief Executive Said Darwazah, Executive Vice Chairman Mazen Darwazah and Non-Executive Director Mohammed Al-Husry each acquired 50,000 shares.
Said Darwazah is a shareholder in Darhold with an equity interest of 21.49%, Mazen Darwazah holds a 10.82% stake and Mohammed Al-Husry has a 7.95% stake. All three are directors of Darhold.
Hikma did not reveal the stake held by the three directors or Darhold after the transaction.
The stock was down 0.4% to 2,104.00p per share on Thursday.
Copyright 2016 Alliance News Limited. All Rights Reserved., source Alliance News